Flatt Jumps to Synthetic Genomics

San Diego’s Synthetic Genomics, which said last year it’s getting at least $300 million from ExxonMobil to develop algae-based biofuels, has named James Flatt as its new chief technology officer, effective May 19. Flatt previously served as the senior vice president of research at Mascoma Biosciences, a cellulosic ethanol developer that moved last fall from Boston to Lebanon, NH.

Bruce V. Bigelow was the editor of Xconomy San Diego from 2008 to 2018. Read more about his life and work here. Follow @bvbigelow

Trending on Xconomy